Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

‘America is going full Joker’
Lends NYC home to Turner?
Birthday celebration moved
To resume negotiations
Clinton taunts Putin
Released in error, captured
FAA ends Blue Origin probe
Pilot error killed billionaire
Drug-test welfare recipients?
Passes formal dress code
'X will be profitable in 2024’
Tech CEO murder suspect
Uber names new CFO
Apologizes for tribute to vet
Is the news racist?
To host reality show spinoff
Cardin replaces Menendez
2nd GOP debate takeaways
Out of US Open Cup final
Philippe strengthens
Attacks Biden over EVs
AL Rep. Rogers indicted
Airlines 'went too far’: CEO
Diamondbacks cut Davies
US oil prices surge
2-yr extension, named captain
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
223,000 results
WISH-TV
5h
Health Spotlight: First FDA-approved drug to slow Alzheimer’s
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...
朝日新聞社9d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...
wreg
4h
FDA advisers vote against experimental ALS treatment pushed by patients
Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig’s disease at a Wednesday ...
ENDPOINTS NEWS
10h
Ad­comm rec­om­mends FDA re­ject Brain­Stor­m's ALS drug af­ter com­pa­ny filed over protest
A panel of independent experts on Wednesday recommended the FDA reject an experimental ALS drug developed by the biotech BrainStorm Cell Therapeutics, marking another defeat for the long embattled ...
Afro16d
Why is Medicare rationing Alzheimer’s drugs?
The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
The Courier-Journal7d
Delaying Alzheimer's: Norton begins administering new drug to slow dementia progression
Every two weeks, Pam Jeffries settles into an armchair and waits for an infusion of a groundbreaking treatment for her memory loss. The new drug, which was approved by the FDA earlier this year ...
Medical Xpress26d
Unlocking how the new Alzheimer's drug lecanemab works
Approved by the FDA earlier this year, the Alzheimer's therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide called amyloid-beta (Aβ), which is thought to be ...
Sentinel Colorado
1d
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
"FDA is the 800-pound gorilla here and if they're convinced that the drug doesn't work it's very hard to change their minds," ...
The Financial Times24d
Vivek Ramaswamy’s FDA ‘corruption’ claims disavowed by Roivant
We’ll send you a myFT Daily Digest email rounding up the latest Vivek Ramaswamy news every morning. US biotech company Roivant Sciences has moved to distance itself from its founder, Vivek ...
Salon14d
Navigating new Alzheimer's drugs can be confusing and expensive. So do they really help patients?
For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...
The Boston Globe27d
Drug firms test medicines to halt Alzheimer’s before symptoms appear
Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft. The first was her Polish-born maternal ...
The Edwardsville Intelligencer
2d
After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
TOKYO (AP) — Japan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices